Mediation analysis for the relationship between dyslipidemia and coronary artery disease via hypersensitive C-reactive protein in a case-control study
Authors:
- 21 May 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 31 (7) , 613-619
Abstract
Background: The pathological basis of coronary artery disease (CAD) is atherosclerosis which is associated with inflammation and dyslipidemia. However, the involvement of hypersensitive C-reactive protein (hs-CRP) in lipid metabolism and how it affects the pathogenesis of CAD is uncertain. Objective: To explore whether the relationship between dyslipidemia and CAD is partly mediated by hs-CRP levels. Methods: Three hundred fifteen pairs of randomly sexand age-matched CAD and non-CAD subjects collected from Zhongda Hospital Affiliated to Southeast University were involved in the final analysis. We gathered information about each subjects clinical history as well as their results of detected hs-CRP and lipid levels. Linear regression analysis was used to determine the association between dyslipidemia and hs-CRP levels in which univariate and multivariate logistic regression analyzes were performed to determine the relationship between hs-CRP levels and CAD as well as dyslipidemia and CAD. Mediation analysis was used to evaluate whether hs-CRP levels act as a mediator of the relationship between dyslipidemia and CAD. Results: Dyslipidemia and hs-CRP levels were significantly associated with an increased risk of CAD, with β = 0.594 (P = 0.001) and β = 0.016 (P = 0.024), respectively, and there was a correlation between dyslipidemia and hs-CRP levels (β = 3.273, P = 0.004). Mediation analysis results revealed that the correlation between dyslipidemia and CAD was 8.27% mediated by hs-CRP levels with a direct effect of 0.621 and an indirect effect of 0.056. Conclusion: Hs-CRP levels played a partial mediation role in the association between dyslipidemia and CAD.Keywords
This publication has 35 references indexed in Scilit:
- Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research GroupArthritis Care & Research, 2012
- Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery diseaseEuropean Journal of Preventive Cardiology, 2011
- Effect size measures for mediation models: Quantitative strategies for communicating indirect effects.Psychological Methods, 2011
- hs-CRP and oxidative stress in young CAD patients: A pilot studyIndian Journal of Clinical Biochemistry, 2008
- Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery DiseaseCirculation, 2007
- Required Sample Size to Detect the Mediated EffectPsychological Science, 2007
- Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studiesJournal of Molecular and Cellular Cardiology, 2006
- Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the hostJournal of Lipid Research, 2004
- C-reactive protein elevation and disease activity in patients with coronary artery diseaseEuropean Heart Journal, 2004
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJACC, 1998